Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (41-50 of 260) with videos related to

Pageof 26
Sort By:
Current Opinion in Pharmacology|June 29, 2015
Drugging PI3K in cancer: refining targets and therapeutic strategiesTimothy A Yap, Lynn Bjerke, Paul A Clarke, et al.
Cancer Discovery|June 4, 2017
Targeting <i>BRAF</i>-Mutant Colorectal Cancer: Progress in Combination StrategiesRaghav Sundar, David S Hong, Scott Kopetz, et al.
Cancer Biology & Medicine|July 27, 2016
Immuno-oncology combinations: raising the tail of the survival curveSamuel J Harris, Jessica Brown, Juanita Lopez, et al.
Cancer Discovery|July 3, 2016
CDK4/6 Inhibitors: Promising Opportunities beyond Breast CancerJoline S J Lim, Nicholas C Turner, Timothy A Yap
Chinese Journal of Cancer|May 7, 2013
Targeting the PI3K-AKT-mTOR signaling network in cancerKhurum H Khan, Timothy A Yap, Li Yan, et al.
British Journal of Cancer|December 17, 2020
The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage responseNiamh Coleman, Bingnan Zhang, Lauren A Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Combining Molecularly Targeted Agents: Is More Always Better?Raghav Sundar, Nicola Valeri, Kevin J Harrington, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The DNA Damaging Revolution: PARP Inhibitors and BeyondTimothy A Yap, Ruth Plummer, Nilofer S Azad, et al.
Current Problems in Cancer|July 1, 2017
Targeting ATR in cancer medicineRaghav Sundar, Jessica Brown, Alvaro Ingles Russo, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Novel Synthetic Lethal Therapeutic Strategies in Precision OncologyTimothy A Yap, Fiona Simpkins, Marie Porte, et al.
Pageof 26

Showing results (41-50 of 260) with videos related to

Sort By:
Pageof 26
Current Opinion in Pharmacology|June 29, 2015
Drugging PI3K in cancer: refining targets and therapeutic strategiesTimothy A Yap, Lynn Bjerke, Paul A Clarke, et al.
Cancer Discovery|June 4, 2017
Targeting <i>BRAF</i>-Mutant Colorectal Cancer: Progress in Combination StrategiesRaghav Sundar, David S Hong, Scott Kopetz, et al.
Cancer Biology & Medicine|July 27, 2016
Immuno-oncology combinations: raising the tail of the survival curveSamuel J Harris, Jessica Brown, Juanita Lopez, et al.
Cancer Discovery|July 3, 2016
CDK4/6 Inhibitors: Promising Opportunities beyond Breast CancerJoline S J Lim, Nicholas C Turner, Timothy A Yap
Chinese Journal of Cancer|May 7, 2013
Targeting the PI3K-AKT-mTOR signaling network in cancerKhurum H Khan, Timothy A Yap, Li Yan, et al.
British Journal of Cancer|December 17, 2020
The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage responseNiamh Coleman, Bingnan Zhang, Lauren A Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Combining Molecularly Targeted Agents: Is More Always Better?Raghav Sundar, Nicola Valeri, Kevin J Harrington, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The DNA Damaging Revolution: PARP Inhibitors and BeyondTimothy A Yap, Ruth Plummer, Nilofer S Azad, et al.
Current Problems in Cancer|July 1, 2017
Targeting ATR in cancer medicineRaghav Sundar, Jessica Brown, Alvaro Ingles Russo, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Novel Synthetic Lethal Therapeutic Strategies in Precision OncologyTimothy A Yap, Fiona Simpkins, Marie Porte, et al.
Pageof 26